| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/AJP.148.4.484 |
| P698 | PubMed publication ID | 2006695 |
| P2093 | author name string | Nemeroff CB | |
| Yao JK | |||
| Bissette G | |||
| Garver DL | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 484-488 | |
| P577 | publication date | 1991-04-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients | |
| P478 | volume | 148 |
| Q43775747 | Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats |
| Q30356261 | Antipsychotic-like effects of a neurotensin receptor type 1 agonist. |
| Q50910079 | Association between neurotensin receptor 1 (NTR1) gene polymorphisms and schizophrenia in a Han Chinese population. |
| Q36311892 | Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions |
| Q34431402 | CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder |
| Q34413353 | Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene |
| Q41922306 | Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions |
| Q58462787 | Comparative sequencing of the proneurotensin gene and association studies in schizophrenia |
| Q48822079 | Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol |
| Q35544527 | Current topics: brain penetrating neurotensin analog |
| Q28580142 | Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody |
| Q33704191 | Does neurotensin mediate the effects of antipsychotic drugs? |
| Q30475349 | Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia |
| Q48635465 | Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q31841102 | Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating. |
| Q41887121 | Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain |
| Q36756393 | Involvement of neuropeptide systems in schizophrenia: human studies |
| Q30459624 | Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia |
| Q61449183 | Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease |
| Q35130197 | Neuropeptides involved in the pathophysiology of schizophrenia and major depression |
| Q28581544 | Neurotensin activates GABAergic interneurons in the prefrontal cortex |
| Q36693006 | Neurotensin agonists: potential in the treatment of schizophrenia |
| Q43786454 | Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties |
| Q28345182 | Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice |
| Q30469501 | Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism |
| Q46638594 | Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen |
| Q24632801 | Neurotensin-deficient mice show altered responses to antipsychotic drugs |
| Q34205082 | Neurotensin: dual roles in psychostimulant and antipsychotic drug responses |
| Q34060785 | Neurotensin: peptide for the next millennium |
| Q73022471 | Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues |
| Q33493599 | Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function |
| Q47818989 | Psychoneuroendocrinology of schizophrenia |
| Q30395034 | Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine |
| Q30477911 | Sensorimotor gating in neurotensin-1 receptor null mice |
| Q46764294 | Sex differences in neurochemical effects of dopaminergic drugs in rat striatum |
| Q34127175 | Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia |
| Q35834247 | Striatal dopamine receptor plasticity in neurotensin deficient mice |
| Q73613784 | Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities |
| Q57727237 | The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia |
| Q36466127 | The neurobiology of neurotensin: focus on neurotensin-dopamine interactions |
| Q44901393 | The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat. |
| Q43571778 | The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat. |
| Q41879435 | The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex |
| Q36544566 | The role of neurotensin in central nervous system pathophysiology: what is the evidence? |
| Q34463402 | The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs |
Search more.